Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
4.285
+0.045 (1.06%)
At close: Oct 13, 2025, 4:00 PM EDT
4.300
+0.015 (0.35%)
After-hours: Oct 13, 2025, 7:39 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $735.19 million as of October 13, 2025. Its market cap has increased by 195.21% in one year.
Market Cap
735.19M
Enterprise Value
644.14M
1-Year Change
195.21%
Ranking
Category
Stock Price
$4.29
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $735.19M, an increase of 68.88%. That is a compound annual growth rate of 12.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 735.19M | 268.51% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |